Company Monitoring Page for LEO-Pharma

latest headlines for company on cafepharma

Gilead roars into JPM25, inking $1.7B inflammation deal with Leo Pharma
Fierce Biotech
Mon, 01/13/25 - 11:03 am
Tags:
Gilead Sciences, JPMHC 2025, LEO Pharma, inflammation
Leo Pharma unveils up to 250 layoffs and relocations amid CEO's revamp
Fierce Pharma
Thu, 10/10/24 - 09:56 am
Tags:
LEO Pharma, layoffs, Pharma CEOs, Christophe Bourdon
Rare disease drug from LEO's Timber felled by failed study
Pharmaphorum
Thu, 08/22/24 - 11:08 am
Tags:
LEO Pharma, Timber Pharmaceuticals, clinical trials, M&A, TMB-001, congenital ichthyosis
LEO Pharma reports positive data from Phase III plaque psoriasis trial
Clinical Trials Arena
Wed, 05/8/24 - 11:01 pm
Tags:
LEO Pharma, clinical trials, psoriasis, Enstilar
After transformation under new CEO, Leo Pharma touts innovation model and financial progress
Fierce Pharma
Tue, 03/12/24 - 06:49 pm
Tags:
LEO Pharma, Pharma CEOs, Christophe Bourdon
Eying Incyte's Opzelura, Leo Pharma shares data for JAK cream in hand eczema
Fierce Pharma
Sun, 10/15/23 - 11:52 pm
Tags:
LEO Pharma, delgocitinib, clinical trials, eczema, hand eczema
LEO Pharma to Acquire Timber Pharmaceuticals
Dermatology Times
Mon, 08/21/23 - 07:58 pm
Tags:
LEO Pharma, M&A, Timber Pharmaceuticals, dermatology
Further shuffling at Leo Pharma as dermatology drugmaker splits R&D
Endpoints
Wed, 03/15/23 - 10:05 am
Tags:
LEO Pharma, R&D, dermatology
Leo Pharma announces positive results for hand eczema study
Pharmaphorum
Mon, 02/13/23 - 10:23 am
Tags:
LEO Pharma, clinical trials, eczema, chronic hand eczema, delgocitinib
Leo Pharma picks Christophe Bourdon as CEO after one-year stint at failed Danish meme stock Orphazyme
Fierce Biotech
Mon, 01/31/22 - 11:42 pm
Tags:
LEO Pharma, Pharma CEOs, Christophe Bourdon
Leo Pharma’s Tralokinumab News: What You Need to Know
BioSpace
Thu, 05/20/21 - 11:10 pm
Tags:
LEO Pharma, Adtralza, FDA, atopic dermatitis
FDA hits Leo Pharma with a CRL for what the biotech says are questions about the 'device component' of eczema candidate
Endpoints
Fri, 04/30/21 - 10:43 am
Tags:
LEO Pharma, FDA, atopic dermatitis, eczema, monoclonal antibodies, Dupixent
LEO Pharma’s new R&D lead on driving agility in drug development
Pharmaforum
Wed, 03/24/21 - 11:22 pm
Tags:
LEO Pharma, R&D, Jörg Möller
Leo Pharma offloads a psoriasis asset as their Dupixent rival heads to the FDA
Endpoints
Tue, 07/21/20 - 10:27 am
Tags:
LEO Pharma, psoriasis, Sanofi, Dupixent, LP0058
LEO eyeing 2021 US launch for eczema drug tralokinumab
Pharmaforum
Fri, 07/10/20 - 10:47 am
Tags:
LEO Pharma, eczema, tralokinumab, Sanofi, Dupixent
AI drug discovery startup strikes partnership with LEO Pharma
MedCity News
Thu, 07/2/20 - 12:09 am
Tags:
Repurpose.AI, LEO Pharma, drug discovery, dermatology
AAD 2020 – Leo’s eczema wildcard proves tame
EP Vantage
Fri, 06/12/20 - 08:02 pm
Tags:
LEO Pharma, Sanofi, Regeneron, eczema, atopic dermatitis, AAD, tralokinumab
LEO Pharma mounts another challenge to the eczema giants, betting $40M cash on a drug from China
Endpoints
Wed, 04/15/20 - 10:42 am
Tags:
LEO Pharma, eczema, asthma, clinical trials, FB825, China
Leo's Dupixent rival hits all endpoints in pivotal program
Fierce Biotech
Wed, 12/11/19 - 10:36 am
Tags:
LEO Pharma, atopic dermatitis, tralokinumab, Sanofi, Regeneron, Dupixent
LEO Pharma and PellePharm Announce Collaboration to Advance Rare Skin Disease Therapies Worth up to $760 Million
CP Wire
Tue, 11/20/18 - 10:00 am
Tags:
LEO Pharma, PellePharm, Gorlin Syndrome, dermatology

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.